Cite
HARVARD Citation
Gravina, G. et al. (2016). Erratum to: KPT-330, a potent and selective exportin-1 (XPO-1) inhibitor, shows antitumor effects modulating the expression of cyclin D1 and survivin in prostate cancer models. BMC cancer. 16 (1), p. 1. [Online].